The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| LIQUIDIA CORP | COM NEW | 53635D202 | 63,873,463 | 9,243,627 | SH | SOLE | 9,243,627 | 0 | 0 | |||
| ANIKA THERAPEUTICS INC | COM | 035255108 | 20,543,158 | 715,291 | SH | SOLE | 715,291 | 0 | 0 | |||
| EVOLUS INC | COM | 30052C107 | 12,888,675 | 1,523,484 | SH | SOLE | 1,523,484 | 0 | 0 | |||
| ADMA BIOLOGICS INC | COM | 000899104 | 5,503,249 | 1,662,613 | SH | SOLE | 1,662,613 | 0 | 0 | |||
| STANDARD BIOTOOLS INC | COM | 34385P108 | 16,724,758 | 8,576,799 | SH | SOLE | 8,576,799 | 0 | 0 | |||
| VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 3,675,925 | 183,064 | SH | SOLE | 183,064 | 0 | 0 | |||
| SOCIETAL CDMO INC | COM | 75629F109 | 1,281,949 | 1,077,268 | SH | SOLE | 1,077,268 | 0 | 0 | |||
| EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 1,279,776 | 435,298 | SH | SOLE | 435,298 | 0 | 0 | |||
| ALIMERA SCIENCES INC | COM NEW | 016259202 | 1,005,432 | 478,777 | SH | SOLE | 478,777 | 0 | 0 | |||
| EXELIXIS INC | COM | 30161Q104 | 16,498,500 | 850,000 | SH | SOLE | 850,000 | 0 | 0 | |||
| AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 99,529 | 4,333 | SH | SOLE | 4,333 | 0 | 0 | |||